This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Park, P. G. Articles by Schuller, H. M. Search for Related Content PubMed PubMed Citation Articles by Park, P. G. Articles by Schuller, H. M.

ß-Adrenergic Mitogenic Signal Transduction in Peripheral Lung Adenocarcinoma: Implications for Individuals with Preexisting Chronic Lung Disease

Carcinogenesis and Developmental Therapeutics Program, College of Veterinary Medicine, University of Tennessee, Knoxville Tennessee 37909

Peripheral adenocarcinoma (PAC) of the lung has increased dramatically over the last 20 years and is today the leading histological type of lung cancer in smokers and nonsmokers in industrialized countries. There is no apparent explanation for the steep rise in the number of individuals developing this cancer type.

Using assays for the assessment of cell proliferation, receptor binding, and production of cyclic AMP (cAMP), we have identified a ß-adrenergic receptor-mediated mitogenic pathway, which activates cAMP down-stream, in cell lines derived from human peripheral adenocarcinomas that express features of Clara cells. Agonists of ß-adrenergic receptors strongly stimulated cell proliferation, whereas antagonists of this receptor and its associated second messenger, cAMP, were potent inhibitors of this effect. Agonists of ß-adrenergic receptors are the active ingredients of many decongestants and bronchodilators, and such medications are, therefore, likely to stimulate this pathway in vivo. Patients suffering from chronic upper and lower respiratory tract diseases and treated with such medications over many years may, therefore, be at a higher risk than the average population to develop PAC, particularly when simultaneously exposed to carcinogenic environmental factors such as smoking. Because the incidence of chronic respiratory tract diseases has risen in industrizalized countries during the same time frame as PAC, a potential etiological link between the therapy of such nonneoplastic diseases with ß-adrenergic agonists and the risk for PAC should be investigated.

¹ To whom requests for reprints should be addressed, at Department of Pathobiology, University of Tennessee, P.O. Box 1071, Knoxville, TN 37901-1071. Supported by National Cancer Institute Grant CA51211.

Received 2/28/95. Accepted 7/ 6/95.

This article has been cited by other articles:

				R.-J. Chen, Y.-S. Ho, H.-R. Guo, and Y.-J. Wang Rapid Activation of Stat3 and ERK1/2 by Nicotine Modulates Cell Proliferation in Human Bladder Cancer Cells Toxicol. Sci., August 1, 2008; 104(2): 283 - 293. [Abstract] [Full Text] [PDF]

				H. P. S. Wong, L. Yu, E. K. Y. Lam, E. K. K. Tai, W. K. K. Wu, and C.-H. Cho Nicotine Promotes Colon Tumor Growth and Angiogenesis through {beta}-Adrenergic Activation Toxicol. Sci., June 1, 2007; 97(2): 279 - 287. [Abstract] [Full Text] [PDF]

				V. Y. Shin, W. K. K. Wu, K. M. Chu, M. W. L. Koo, H. P. S. Wong, E. K. Y. Lam, E. K. K. Tai, and C. H. Cho Functional Role of {beta}-Adrenergic Receptors in the Mitogenic Action of Nicotine on Gastric Cancer Cells Toxicol. Sci., March 1, 2007; 96(1): 21 - 29. [Abstract] [Full Text] [PDF]

				Z. Jin, M. Xin, and X. Deng Survival Function of Protein Kinase C{iota} as a Novel Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated Bad Kinase J. Biol. Chem., April 22, 2005; 280(16): 16045 - 16052. [Abstract] [Full Text] [PDF]

				M. Xin and X. Deng Nicotine Inactivation of the Proapoptotic Function of Bax through Phosphorylation J. Biol. Chem., March 18, 2005; 280(11): 10781 - 10789. [Abstract] [Full Text] [PDF]

				Z. Jin, F. Gao, T. Flagg, and X. Deng Nicotine Induces Multi-site Phosphorylation of Bad in Association with Suppression of Apoptosis J. Biol. Chem., May 28, 2004; 279(22): 23837 - 23844. [Abstract] [Full Text] [PDF]

				D.L. Weddle, P. Tithoff, M. Williams, and H.M. Schuller {beta}-Adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas Carcinogenesis, March 1, 2001; 22(3): 473 - 479. [Abstract] [Full Text] [PDF]

				H. M. Schuller, P. K. Tithof, M. Williams, and H. Plummer III The Tobacco-specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Is a {beta}-Adrenergic Agonist and Stimulates DNA Synthesis in Lung Adenocarcinoma via {beta}-Adrenergic Receptor-mediated Release of Arachidonic Acid Cancer Res., September 1, 1999; 59(18): 4510 - 4515. [Abstract] [Full Text] [PDF]